HIV RISK QUESTIONNAIRE (HRQ) STUDY: AN ASSESSMENT OF THE PREDICTIVE VALUE OF A PANEL OF QUESTIONS FOR RECENT INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV)
$4,856,661
| Recipient | VITALANT UEI GKT4L2JZJ622 |
|---|---|
| Award ID | 75F40119P10697 |
| Award amount | $4,856,661 |
| Award type | PURCHASE ORDER |
| Awarding agency | Department of Health and Human Services — Food and Drug Administration |
| NAICS | 541990 — ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES |
| PSC | B537 |
| Set-aside | Unrestricted |
| Start date | Sep 30, 2019 |
| End date | Mar 29, 2023 |
| Place of performance | SCOTTSDALE, AZ |
| Record updated | May 27, 2022 |
View the official award record
More awards won by VITALANT
CHARACTERIZE SEROPREVALENCE OF SARS COV-2 ANTIBODIES IN THE US POPULATION
Department of Health and Human Services · $46,437,074 · May 12, 2020
REDS-IV-P - CENTER FOR TRANSFUSION LABORATORY STUDIES (CTLS), PHASE 1.
Department of Health and Human Services · $8,503,535 · Apr 1, 2019
TTIMS LRCC REQUIREMENT
Department of Health and Human Services · $7,319,311 · Sep 27, 2021
REDS-IV-P CENTER FOR TRANSFUSION LABORATORY STUDIES (CTLS) PHASE 2
Department of Health and Human Services · $4,906,930 · Apr 1, 2021
REDS-IV-P BRAZIL TRANSFUSION SAFETY RESEARCH PROGRAM PHASE 2
Department of Health and Human Services · $4,284,223 · Apr 1, 2021
Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.
Search open bids